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Brief Clinical ReportsPreserved homograft function 32 years after surgery in
a young patientIsmail El-Hamamsy, MD,a James T. Willerson, MD,b and Magdi H. Yacoub, FRS,a London,
United Kingdom, and Houston, TexThe quest for the ideal valve substitute, namely, a valve
requiring no anticoagulation and free from early valve
degeneration with a good hemodynamic profile, remains un-
solved despite continued research over the past 50 years. The
present report describes a well-functioning aortic root homo-
graft 32 years after implantation. It illustrates the potential
longevity of implanted tissue valves and highlights the
need to better understand the cellular and molecular physiol-
ogy of heart valves as well as the mechanisms responsible
for structural valve degeneration.FIGURE 1. Echocardiographic evaluation 32 years after homograft total aortic r
tract and aortic root with good opening of the valve (arrow) and sinus expansion
view of the left ventricle showing good ventricular function.
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In 1977, a 36-year-old woman with a history of rheumatic
fever complicated by rheumatic valve disease sought treat-
ment. She reported having fatigue and exercise intolerance.
Catheterization showed mixed aortic valve disease with
a peak transvalvular gradient of 50 mm Hg and moderate
aortic regurgitation. There was concomitant moderate mitral
valve stenosis. Left ventricular function and pulmonary ar-
tery pressures were within normal limits. Coronary angiog-
raphy showed a 70% ostial stenosis in the right coronary
artery. Total aortic root replacement using a ‘‘homovital’’
homograft with reimplantation of the coronary arteries was
performed. Digital mitral valvotomy and a right coronary
bypass using a saphenous vein graft were also performed.
Postoperative recovery was uneventful.
The patient thereafter led a healthy and active life. She had
no valve-related complications. She underwent mitral valve
replacement with a mechanical prosthesis in 1996. At last
follow-up, 32 years after the initial operation, she continues
to be very active. Her latest echocardiogram in July 2009oot replacement showing (A) a long-axis view of the left ventricular outflow
, (B) short-axis end-diastolic view of the left ventricle, and (C) end-systolic
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Brief Clinical Reportsshowed trace aortic regurgitation and a mean gradient of 8
mm Hg. Estimated aortic orifice area is 2.1 cm2 (indexed or-
ifice area: 1.3 cm2/m2). Left ventricular end-diastolic and
end-systolic diameters are 46 and 30 mm, respectively
(Figure 1). Left ventricular ejection fraction is preserved.
DISCUSSION
To our knowledge, this case represents the longest follow-
upof a functional aortic homograft after implantation.Remark-
ably, the patient was in her mid-30s when she underwent
surgery, putting her at high risk of early valve degeneration.
Several points emerge from this case. Although we and others
have sought to determine the precise mechanisms responsible
for tissue valve deterioration,1,2 morework is required to trans-
late this knowledge into improved patient outcomes. Homo-
graft degeneration is partly due to direct and indirect immune
reactions elicited by the persistence of living cells and protein
remnants on the homograft cusps and wall. Interestingly,
this case illustrates what we call the ‘‘homograft paradox,’’
namely, that fresh homografts appear to be more durable and
exhibit lessdegenerationdespite a higher likelihoodof eliciting
an immune reaction. This might be due to their better ability to
adapt to their new hemodynamic environment, therefore re-
ducing stresses on the aortic cusps and wall. Similarly, use of
a total root replacement technique (versus subcoronary implan-
tation) is thought to favor the long-term durability of homo-
grafts,3 possibly due to better biomechanics of the homograft
root, decreased mechanical stresses on the cusps, and more
optimal ventricular workload and coronary blood flow.4
Bioprosthetic valve degeneration is characterized by
lipid-rich inflammatory cell infiltration,2 a process similarFrom the Division of Cardiac Surgery, University of Verona, Verona, Italy
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e142 The Journal of Thoracic and Cardiovascular Surto atherosclerosis, and is associated with smoking and con-
comitant coronary artery disease.5 In our patient, no recur-
rence of coronary artery disease was evidenced, mirroring
the durability of the homograft. Her latest lipid profile is
normal; she is normotensive, physically active, and eats
a balanced diet. This underlines the potential impact of
a healthy lifestyle and control of atherosclerotic risk factors
in tissue valve recipients.
CONCLUSION
In conclusion, this case demonstrates the potential long-
term functionality of an aortic homograft implanted as a total
root in a young patient. With increased understanding of the
mechanisms responsible for tissue valve degeneration, it is
hoped that the durability of these valve substitutes can be
greatly enhanced, including in the younger patient popula-
tion.
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tive randomized trial. Circulation. In press.Pericardial defects and traumatic tricuspid valve rupture:
A serendipitous association?Giovanni Battista Luciani, MD, Fabio Patelli, MD, Giuseppe Faggian, MD, and Alessandro Mazzucco, MD,
Verona, ItalyTraumatic tricuspid valve rupture (TTR) after blunt chest
trauma is a fairly infrequent condition, although it is the
most commonly reported traumatic valve injury.1 Rupture
of the pericardium after chest trauma is relatively more
frequent, but very few cases of TTR associated with pericar-
dial rupture have been identified.2 Congenital pericardial
defects are also rare with nearly 200 cases reported to
date.3 Here reported is the case of successful repair of
TTR associated with a pericardial defect. The issue whether
the pericardial defect is a consequence of trauma orgery c June 2010
